Trial intelligence / Profile preview

Statins in a Community Heart Failure Population

NCT00795912Phase 4Completed

Sponsor
St. Vincent's University Hospital
Start
May 2003
Primary completion
Nov 2005
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, open-label trial of atorvastatin in heart failure (HF) (2 arms), sponsored by St. Vincent's University Hospital. Primary endpoints: High Sensitivity C-Reactive Protein at 6 months, Tumor Necrosis Factor alpha at 6 months and 1 more. Started May 2003; status: completed.

02

Drugs

atorvastatin
03

Conditions

heart failure (HF)

Beyond the preview

Go deeper on NCT00795912.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00795912.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call